OPKO Health (OPK) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts OPK Hot Sheet
Price: $1.59 -3.05%
EPS Growth %: -333.3%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -333.3%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
OPKO Health (NYSE: OPK) reported Q4 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $276.2 million versus the consensus estimate of $286.52 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- Braze stock tumbles 10% on weak third quarter EPS guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
